A Study of SLS-002 (Intranasal Racemic Ketamine) in Adults With Major Depressive Disorder at Imminent Risk of Suicide

Clinical trial NCT04669665 · COMPLETED

Trial details

NCT number: NCT04669665
Sponsor: Seelos Therapeutics, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Depressive Disorder, Major Suicidal

Start date: 2020-12-17
Primary completion: 2023-06-17
Enrollment: 164

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.